BENDHEIM JACK (President and CEO) sold 24.1% of their position (14.13K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $569.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Class A Common Stock
Shares
−7.55K
Price / share
$40.32
Trade value
$304.42K
% of position
Class A Common Stock
Shares
+20K
Price / share
—
Trade value
—
% of position
Class A Common Stock
Shares
−3.26K
Price / share
$40.46
Trade value
$131.82K
% of position
Class A Common Stock
Shares
−393.00
Price / share
$41.14
Trade value
$16.17K
% of position
Class A Common Stock
Shares
−2.93K
Price / share
$40.02
Trade value
$117.35K
% of position
Net shares
+5.87K
Net value
-$569.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 1/13/2026 | S · Sale | −7.55K | $40.32 | $304.42K | 19.5% | 38.66K | 31.11K |
| Class A Common Stock Indirect | 1/14/2026 | C · Conversion | +20K | — | — | 64.3% | 31.11K | 51.11K |
| Class A Common Stock Indirect | 1/14/2026 | S · Sale | −3.26K | $40.46 | $131.82K | 6.4% | 51.11K | 47.85K |
| Class A Common Stock Indirect | 1/14/2026 | S · Sale | −393.00 | $41.14 | $16.17K | 0.8% | 47.85K | 47.46K |
| Class A Common Stock Indirect | 1/15/2026 | S · Sale | −2.93K | $40.02 | $117.35K | 6.2% | 47.46K | 44.52K |
| Total | +5.87K | -$569.75K | ||||||
Class B Common Stock
Class A Common Stock
20K shares
Shares
−20K
Strike price
0
Held after
19.94M
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Class B Common Stock Indirect | Class A Common Stock20K shares | 1/14/2026 | C · Conversion | −20K | 0 | — | 19.94M |
Class A Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |